Sailong Pharmaceutical Group Co.,Ltd.

SZSE:002898 Stock Report

Market Cap: CN¥1.7b

Sailong Pharmaceutical GroupLtd Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Nangui Cai

Chief executive officer

CN¥511.4k

Total compensation

CEO salary percentagen/a
CEO tenure10yrs
CEO ownershipn/a
Management average tenure7yrs
Board average tenure3.7yrs

Recent management updates

Recent updates

Some Shareholders Feeling Restless Over Sailong Pharmaceutical Group Co.,Ltd.'s (SZSE:002898) P/S Ratio

Oct 01
Some Shareholders Feeling Restless Over Sailong Pharmaceutical Group Co.,Ltd.'s (SZSE:002898) P/S Ratio

Impressive Earnings May Not Tell The Whole Story For Sailong Pharmaceutical GroupLtd (SZSE:002898)

Apr 26
Impressive Earnings May Not Tell The Whole Story For Sailong Pharmaceutical GroupLtd (SZSE:002898)

Subdued Growth No Barrier To Sailong Pharmaceutical Group Co.,Ltd. (SZSE:002898) With Shares Advancing 27%

Mar 08
Subdued Growth No Barrier To Sailong Pharmaceutical Group Co.,Ltd. (SZSE:002898) With Shares Advancing 27%

CEO

Nangui Cai (62 yo)

10yrs

Tenure

CN¥511,400

Compensation

Mr. Nangui Cai is Non-Independent Chairman of Sailong Pharmaceutical Group Co. Ltd. from December 11, 2014 and is its CEO.

Leadership Team

NamePositionTenureCompensationOwnership
Nangui Cai
Chairman & CEOno dataCN¥511.40kno data
Jian Feng Li
Deputy GM & Director9.3yrsCN¥445.30kno data
Zhang Xu
Board Secretary7yrsCN¥483.00kno data
Xing Wang
Deputy General Manager1.8yrsCN¥524.50kno data

7.0yrs

Average Tenure

42yo

Average Age

Experienced Management: 002898's management team is seasoned and experienced (7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Nangui Cai
Chairman & CEO10yrsCN¥511.40kno data
Jian Feng Li
Deputy GM & Director9.3yrsCN¥445.30kno data
Zhang Xu
Board Secretary7yrsCN¥483.00kno data
Lin Tang
Director10yrsCN¥401.80k5.47%
CN¥ 95.6m
Zhixiang Long
Chairman of the Supervisory Boardless than a yearCN¥359.20kno data
Xiaoxin Chen
Independent Director3.7yrsCN¥120.00kno data
Chuanyun Pan
Independent Director3.7yrsCN¥120.00kno data
Dawen Liu
Deputy GM & Non-Independent Directorless than a yearCN¥568.60kno data
Yongjun Deng
Non-Independent Directorless than a yearno datano data
Bei Zhou
Non-Employee Supervisor10yrsno datano data
Gongfen Li
Independent Director1.8yrsCN¥100.00kno data
Haibo Huang
Supervisor1.8yrsno datano data

3.7yrs

Average Tenure

51yo

Average Age

Experienced Board: 002898's board of directors are considered experienced (3.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 08:39
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sailong Pharmaceutical Group Co.,Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yifan JiangChina Merchants Securities Co. Ltd.
Jiaxi XuIndustrial Securities Co. Ltd.